Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on tariffs on the industry. Trump's Department of Commerce is looking into ...

Eli Lilly has escalated its legal offensive against compounding pharmacies accused ... to produce and sell compounded versions even after supply concerns were addressed. Just last month, Lilly scored ...

Eli Lilly has unleashed another wave of litigation against four telehealth brands in its widening legal war with sellers of alternative versions of its popular diabetes and weight-loss drugs.

Eli Lilly is throwing legal punches in a pharmaceutical showdown over tirzepatide, its prized ingredient in diabetes and weight-loss treatments. The company filed lawsuits against four ...

Eli Lilly (LLY) is among the list of large-cap ... be enough to weaken the threat of tariffs on the sector. "Declare victory and move on [would] be my advice," he said. Anjalee Khemlani is the ...

Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages and lowered blood sugar in patients during a clinical trial.

The lawsuit filings are the latest turn in a long running legal saga between GLP-1RAs makers and compounders. Eli Lilly has filed a lawsuit against four telehealth platforms selling compounded ...

Eli Lilly recently announced the impressive results of its SURMOUNT-5 trial, highlighting Zepbound's efficacy over Wegovy in weight management. This promising development was disclosed alongside ...